Read the Research

Cyclosporine's history as a hair loss candidate goes back further than most pipeline compounds we cover, all the way to a small human trial in 1990, and it t...

In July 2024, a small Delaware biotech called Dermaliq Therapeutics announced that its topical hair loss candidate, DLQ01, had produced a larger reported inc...

Low-dose oral minoxidil has become one of the most widely used off-label hair loss treatments of the past decade, prized for the convenience of a tablet over...

AMP-303 is an injectable treatment from Amplifica Holdings Group, and its origin story is unusual: it traces back to a decade of research into why hairy mole...

GT20029 is a topical drug from Kintor Pharmaceutical, the same China-based company behind KX-826 (pyrilutamide), but it works through a meaningfully differen...

ET-02 is a topical small molecule from Eirion Therapeutics, and it's getting attention for two reasons: an explicitly non-hormonal mechanism aimed at hair fo...

A single-cell RNA sequencing study published in the past month has identified a new signalling pathway that appears to be switched off in balding hair follic...

Most hair loss drugs in development still work somewhere along the androgen pathway, the same territory finasteride and dutasteride occupy. ABS-201, develope...

Cetirizine is a second-generation antihistamine, sold over the counter for hay fever and hives. It has no obvious connection to hair. The rationale for using...

Tretinoin comes up constantly in hair loss discussions, almost always attached to minoxidil. The standard claim is that tretinoin helps minoxidil work better...